Results 121 to 130 of about 35,947 (209)

Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index

Journal of Dermatological Treatment
Background Psoriasis is a chronic inflammatory disease associated with systemic comorbidities. The Charlson Comorbidity Index (CCI) quantifies comorbidity burden and estimates survival, but its relationship with psoriasis severity and biologic therapies ...
Nicoletta Bernardini, Annunziata Dattola, Giuseppe Paolo Antonio Gemma, Laura Atzori, Fabio Artosi, Gabriele Biondi, Elena Campione, Aldo Cuccia, Paolo Dessi, Antonella Di Cesare, Martina Dragotto, Alessia Frau, Domenico Giordano, Annamaria Mazzotta, Matteo Megna, Alessandra Michelucci, Maria Antonia Montesu, Cristina Mugheddu, Corinne Orsini, Gianluca Pagnanelli, Salvatore Panduri, Severino Persechino, Luca Potestio, Francesca Prignano, Federica Ricceri, Giuseppe Rizzuto, Emanuele Trovato, Marco Virone, Giovanni Pellacani, Concetta Potenza, Nevena Skroza   +30 more
doaj   +1 more source

Nutritional Status in Pediatric Psoriasis: A Case–Control Study in a Tertiary Care Referral Centre

Children
Background: Psoriasis and obesity are chronic, inflammatory diseases, sharing certain pathophysiological factors. Psoriasis, increasingly viewed as a systemic inflammatory condition, may have various symptoms beyond the skin manifestations. Methods: This
Adelina-Maria Sendrea, Sinziana Cristea, Carmen Maria Salavastru   +2 more
doaj   +1 more source

Psoriasis Area and Severity Index Clinical Classification [PDF]

, 2020
openaire   +1 more source

Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance. [PDF]

Dermatol Ther (Heidelb), 2020
Wu AG, Conway J, Barazani L, Roy B, Cline A, Pereira F.   +5 more
europepmc   +1 more source

The metabolomics of psoriatic disease. [PDF]

, 2017
Metabolomics is an emerging new "omics" field involving the systematic analysis of the metabolites in a biologic system. These metabolites provide a molecular snapshot of cellular activity and are thus important for understanding the functional changes ...
Afifi, Ladan, Chang, Hsin Wen, Jeon, Caleb, Lee, Kristina, Liao, Wilson, Trivedi, Megha, Yan, Di   +6 more
core  

S-MAPA: bridging the gap in psoriasis severity assessment

Dermatology Reports
The Psoriasis Area and Severity Index (PASI) is widely used to evaluate psoriatic disease activity in clinical settings; however, its limitations hinder its practicality in routine use.
Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van   +2 more
doaj   +1 more source

Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice

Actas Dermo-Sifiliográficas (English Edition), 2019
E, Del Alcázar Viladomiu, N, Lamas Doménech, M, Salleras Redonnet   +2 more
openaire   +2 more sources

Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index).

Anais brasileiros de dermatologia, 2011
Developed in 1978, the PASI (Psoriasis Area and Severity Index) is a method to rate psoriasis severity. Since then, it has been criticized for being extremely long, complex and for yielding significantly divergent interpretations.To determine the PASI inter-rater reliability among three independent evaluators examining the same patients.Cross-sectional
Joana Ribeiro Costa de, Faria, Aline Rezende, Aarão, Luiz Miguel Zabaleta, Jimenez, Oscar Hernández, Silva, João Carlos Regazzi, Avelleira   +4 more
openaire   +1 more source

Health utility by Psoriasis Area and Severity Index response status after biologic induction therapy in Chinese patients with moderate to severe psoriasis. [PDF]

J Comp Eff Res
Jian L, Zhang L, Zhou G, Wang X, Hu K, Duan Y, Zhang M, Tan L, Chen W, Li B, Kuang Y.   +10 more
europepmc   +1 more source

Morphological Characteristics of Psoriatic Lesions Affect the Accuracy and Reliability of Severity Assessments: Proposal for New Working Criteria for the Psoriasis Area and Severity Index. [PDF]

Ann Dermatol, 2019
Choi CW, Kim BR, Yang S, Youn SW.
europepmc   +1 more source